Health British Columbia

Longleaf Partners Fund exits BIO

Longleaf Partners Fund lagged in Q2 2026; see returns vs S&P 500 and Russell 1000 Value, plus a new healthcare buy and Bio-Rad exit—read now.

BC Post Staff Source: Seeking Alpha Jul 13, 2026 Updated Jul 13, 2026 1 min read 6 views

British Columbia Source: Seeking Alpha

Text to audio Audio version available

Longleaf Partners Fund lagged in Q2 2026; see returns vs S&P 500 and Russell 1000 Value, plus a new healthcare buy and Bio-Rad exit—read now.

Published: Jul 13, 2026
Updated: Jul 13, 2026
Source: Seeking Alpha
Category: Health
Read time: 1 min

Key facts

SectionHealth

Open

SourceSeeking Alpha

Open

PublishedJul 13, 2026

UpdatedJul 13, 2026

Why this matters locally

This health story matters locally because it may affect readers, businesses, commuters, families, or public services in British Columbia.

Local impact

BC Post links this item to British Columbia coverage so readers can follow related city updates, weather, traffic, events, and category news in one place.

Timeline

PublishedJul 13, 2026, 7:35 AMThis story was published by BC Post.

ImportedJul 13, 2026, 10:15 AMThe item entered the BC Post source pipeline.

Transparency

Source and credit

BC Post may summarize, organize, and add local context for reader clarity. Original reporting remains with the listed publisher.

Seeking Alpha Published Jul 13, 2026 Imported Jul 13, 2026

Read Original Source

Seeking Alpha Jul 13, 2026